Brief: Cynata Therapeutics Ltd Says Co To Acquire Cyp-006Tk Wound Dressing Technology From Tekcyte
01/07/2024 02:45
July 1 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* CO TO ACQUIRE CYP-006TK WOUND DRESSING TECHNOLOGY FROM
TEKCYTE
* IN CONSIDERATION OF THIS ACQUISITION, CYNATA WILL ISSUE
SHARES
TO THE VALUE OF A$230,000 TO TEKCYTE
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million